文献速递乳腺US乳腺X线

双模态列线图作为辅助工具减少超声与乳腺X线BI-RADS评估不一致后的不必要乳腺活检

A bimodal nomogram as an adjunct tool to reduce unnecessary breast biopsy following discordant ultrasonic and mammographic BI-RADS assessment.
PubMed 文献 · Eur Radiol · 2023-10-16

本回顾性研究纳入两中心706例超声与乳腺X线BI-RADS评估不一致的乳腺病灶,开发双模态列线图。列线图在训练、内部验证和外部测试样本的AUC分别为0.87、0.91和0.92,与超声联用将不必要活检从74%降至44%、漏诊恶性率从13%降至2%;与乳腺X线联用将漏诊恶性率从20%降至6%,63%患者避免不必要活检。

要点

  • 超声与乳腺X线BI-RADS评估不一致时,列线图可提高诊断准确性并减少不必要活检。
  • 列线图与超声联用将不必要活检从74%降至44%,漏诊恶性率从13%降至2%。
  • 列线图与乳腺X线联用将漏诊恶性率从20%降至6%,63%患者避免不必要活检。

核心结论

  • 当超声与乳腺X线BI-RADS评估不一致时,结合列线图可能提高诊断准确性、避免不必要乳腺活检并减少漏诊。

研究设计与样本

  • 回顾性研究,纳入两个医学中心2019年6月至2021年6月间机会性筛查或诊断后超声与乳腺X线BI-RADS评估不一致的706例女性。

诊断标准与关键数值

  • 列线图在训练样本的AUC为0.87(95%CI 0.83-0.91)。
  • 列线图在内部验证样本的AUC为0.91(95%CI 0.87-0.96)。
  • 列线图在外部测试样本的AUC为0.92(95%CI 0.86-0.98)。
  • 列线图与超声联用将不必要活检从74%降至44%,漏诊恶性率从13%降至2%。
  • 列线图与乳腺X线联用将漏诊恶性率从20%降至6%,63%患者避免不必要活检。

临床应用与阅片要点

  • 超声和乳腺X线BI-RADS评估不一致时,可考虑将列线图作为辅助工具整合到诊断流程中。
  • 列线图与超声和乳腺X线联用可提高乳腺癌检出,且不增加不必要活检或漏诊恶性肿瘤的风险。
  • 列线图可提高乳腺X线和超声的观察者间一致性并增强决策一致性。
  • 列线图有潜力作为计算机程序辅助放射科医生识别乳腺癌并做出最佳决策。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To develop a bimodal nomogram to reduce unnecessary biopsies in breast lesions with discordant ultrasound (US) and mammography (MG) Breast Imaging Reporting and Data System (BI-RADS) assessments.

METHODS: This retrospective study enrolled 706 women following opportunistic screening or diagnosis with discordant US and MG BI-RADS assessments (where one assessed a lesion as BI-RADS 4 or 5, while the other assessed the same lesion as BI-RADS 0, 2, or 3) from two medical centres between June 2019 and June 2021. Univariable and multivariable logistic regression analyses were used to develop the nomogram. DeLong's and McNemar's tests were used to assess the model's performance.

RESULTS: Age, MG features (margin, shape, and density in masses, suspicious calcifications, and architectural distortion), and US features (margin and shape in masses as well as calcifications) were independent risk factors for breast cancer. The nomogram obtained an area under the curve of 0.87 (95% confidence interval (CI), 0.83-0.91), 0.91 (95% CI, 0.87 - 0.96), and 0.92 (95% CI, 0.86-0.98) in the training, internal validation, and external testing samples, respectively, and demonstrated consistency in calibration curves. Coupling the nomogram with US reduced unnecessary biopsies from 74 to 44% and the missed malignancies rate from 13 to 2%. Similarly, coupling with MG reduced missed malignancies from 20 to 6%, and 63% of patients avoided unnecessary biopsies. Interobserver agreement between US and MG increased from - 0.708 (poor agreement) to 0.700 (substantial agreement) with the nomogram.

CONCLUSION: When US and MG BI-RADS assessments are discordant, incorporating the nomogram may improve the diagnostic accuracy, avoid unnecessary breast biopsies, and minimise missed diagnoses.

CLINICAL RELEVANCE STATEMENT: The nomogram developed in this study could be used as a computer program to assist radiologists with detecting breast cancer and ensuring more precise management and improved treatment decisions for breast lesions with discordant assessments in clinical practice.

KEY POINTS: • Coupling the nomogram with US and mammography improves the detection of breast cancers without the risk of unnecessary biopsy or missed malignancies. • The nomogram increases mammography and US interobserver agreement and enhances the consistency of decision-making. • The nomogram has the potential to be a computer program to assist radiologists in identifying breast cancer and making optimal decisions.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Xu Z, Lin Y, Huo J, et al. A bimodal nomogram as an adjunct tool to reduce unnecessary breast biopsy following discordant ultrasonic and mammographic BI-RADS assessment. Eur Radiol. 2023. PMID: 37840099. doi:10.1007/s00330-023-10255-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。